Crispr Therapeutics Ag (CRSP)

$68.60 3.55 (4.92%)

16:00 EDT CRSP Stock Quote Delayed 30 Minutes

Why Are Gene Editing Stocks NTLA, ALNY, CRSP, BEAM Up Today?

By Shrey Dua, InvestorPlace Assistant News Writer Aug 3, 2022

Gene editing stocks are a bright spot on the market today after Alnylam announced the success of one of its RNAi therapies, Patisiran.

7 Undervalued Biotech Stocks to Buy Before They Boom

6 Cathie Wood Stocks to Buy on the Dip

The 7 Best Biotech Stocks to Buy

Volume:

Previous Close -

Market Cap 5.35B

PE Ratio -8.44

EPS -8.13

Volume (Avg. Vol.) 1.45M

Day's Range $68.21 - $71.77

52-Week Range $42.51 - $129.50

Dividend & Yield N/A (N/A)

CRSP Stock Predictions, Articles, and Crispr Therapeutics Ag News

From InvestorPlace
From the Web

7 No-Brainer Biotech Stocks to Add to Your Buy List

By Josh Enomoto, InvestorPlace Contributor Jun 9, 2022

With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile.

5 Cathie Wood Stocks to Buy Now

By Tezcan Gecgil, InvestorPlace Contributor May 16, 2022

ARK Invest funds led by Cathie Wood seek long-term capital growth and focus mainly on disruptive innovation. Here's a look a five related stocks to consider.

3 Cathie Wood Stocks to Count on in Q2

By Muslim Farooque Apr 26, 2022

These Cathie Wood Stocks have their risks but offer a massive upside potential ahead

7 Potential Biotech Stocks Buyout Targets in 2022

By Shanthi Rexaline Apr 21, 2022

Big biopharma companies usually rely on M&A to get immediate access to a new class of drug or technology, fill in the gap in their pipeline and compensate for revenue loss from patent expiration of blockbuster products.

3 Best Stocks to Trade Right Now

By Chris Tyler, InvestorPlace Contributor Mar 24, 2022

Get past the persistently bearish headlines, and you'll find stocks to trade long in emerging bull markets that could be lucrative.

3 Ark Invest Most-Shorted Stocks to Buy

By Chris Tyler, InvestorPlace Contributor Mar 11, 2022

These most-shorted stocks have investors seeing red, but there is a silver lining that's playing out on the price chart for today's buyers.

3 Cathie Wood Stocks to Buy

By Chris Tyler, InvestorPlace Contributor Mar 9, 2022

Don't buy Cathie Wood stocks because the market was singing on Wednesday, purchase them because of a much bigger and bullish picture.

Peloton Isn’t the ONLY Takeover Target. What Companies Could Be Bought Out in 2022?

By Tezcan Gecgil, InvestorPlace Contributor Feb 23, 2022

Savvy investors can generate lucrative returns by investing in companies that look like prime takeover targets. This article speculates on a number of takeover targets of 2022.

7 Stock Bargains Worth a Look After the Most Recent Pullback

By Chris Lau, InvestorPlace Contributor Dec 27, 2021

Value investors may choose to buy stocks that are out of favor and from among beaten up stock bargains in a variety of sectors.

10 Bargain Stocks to Buy After Falling 30% in 2021

By Will Ashworth, InvestorPlace Contributor Dec 20, 2021

If you’re looking for bargain stocks to buy that are down 30% or more in 2021, that’s not an easy task. Here are 10 that fit the bill.

CRISPR Therapeutics Is One of Today’s Best Biotech Value Investments

By David Moadel, InvestorPlace Contributor Dec 9, 2021

Don't let the downtrend in CRSP stock fool you; the company is still making headway in advancing potentially life-changing therapeutics.

Being First Is Not Enough For Crispr Therapeutics

By Dana Blankenhorn, InvestorPlace Contributor Nov 15, 2021

CRSP stock is facing competition and meeting skepticism as the company tries to turn CRISPR-CAS9 into profitable drug therapies.

CRSP Stock: The Cancer Study News Sending Crispr Therapeutics Lower Today

By William White, InvestorPlace Writer Oct 13, 2021

Crispr Therapeutics (CRSP) stock is falling on Wednesday following the release of new results from a Phase 1 clinical trial.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Oct 13, 2021

We're at the halfway point of the trading week and that has us checking in on the biggest pre-market stock movers for Wednesday!

7 Cathie Wood Stocks Every Growth Investor Needs In Their Portfolio

By Chris MacDonald, InvestorPlace Contributor Sep 28, 2021

These top seven stocks among Cathie Wood's top holdings are ones investors may be enticed to consider right now.

7 Gene Editing Stocks Promising to Change our DNA

By Chris Markoch Sep 15, 2021

Gene editing stocks will take off as the underlying tech moves from fiction to fact and companies put their products on the market.

7 Cathie Wood Stock Favorites to Keep on Your Radar

By Faizan Farooque Sep 10, 2021

Cathie Wood and her funds are generating a lot of interest among investors for smart picks, and these Cathie Wood stocks are worth a look.

3 Cathie Wood Stocks To Trade for Bulls as Well as Bears

By Chris Tyler, InvestorPlace Contributor Sep 9, 2021

As the saying goes, bulls and bears make money. And today in these three Cathie Wood stocks both camps should be ready for action

Gene Editing Stocks: The Trial News Lifting NTLA, CRSP and EDIT Stocks Today

By Chris MacDonald, InvestorPlace Contributor Aug 23, 2021

Today, gene editing stocks are getting a big boost after an intriguing data release by Editas for the company's new SLEEK technology.

Updated Clinical and Financial Data Make the Case for CRISPR Therapeutics

By David Moadel, InvestorPlace Contributor Aug 19, 2021

Looking for a terrific value in the biotechnology space? It doesn't get much better than CRSP stock, which just entered a buy zone.

TELECOM TRIUMPH?

Crispr Therapeutics Ag (CRSP)

Why Are Gene Editing Stocks NTLA, ALNY, CRSP, BEAM Up Today?

7 Undervalued Biotech Stocks to Buy Before They Boom

6 Cathie Wood Stocks to Buy on the Dip

The 7 Best Biotech Stocks to Buy

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

TELECOM TRIUMPH?

Crispr Therapeutics Ag (CRSP)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CRSP Stock Predictions, Articles, and Crispr Therapeutics Ag News

Subscriber Sign in